Status:

UNKNOWN

Clopidogrel for the Prevention of Exacerbations in Severe COPD

Lead Sponsor:

Lady Reading Hospital, Pakistan

Collaborating Sponsors:

Pakistan Chest Society, Pakistan

Conditions:

COPD

COPD Exacerbation Acute

Eligibility:

All Genders

40-80 years

Phase:

PHASE3

Brief Summary

Chronic Obstructive Pulmonary Disease (COPD) is a debilitating respiratory disorder characterized by gradual and progressive airflow limitation. It has been hypothesized that clopidogrel may have a ro...

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) is a debilitating respiratory disorder characterized by gradual and progressive airflow limitation. It is a huge worldwide health issue as well as a major ...

Eligibility Criteria

Inclusion

  • Patients diagnosed with severe COPD (GOLD stage III or IV based on FEV1)
  • Patients with a history of at least one exacerbation in the past year.
  • Patients who are able to understand and provide informed consent.
  • Patients willing and able to comply with the study protocol and attend follow-up visits.
  • Patients who are between the ages of 40 and 80 years.
  • Either gender

Exclusion

  • Patients who have previously experienced serious medical issues, like a recent heart attack or stroke (within six months),
  • Patients who are known to be hypersensitive to clopidogrel.
  • People who have a history of gastrointestinal bleeding or any other health issue that could make them more likely to bleed.
  • Women who are pregnant or nursing.
  • Patients who are being treated with additional antiplatelet or anticoagulant medications.
  • Patients who are being treated with clopidogrel for any other indication.
  • People who suffer from severe renal or liver illness.

Key Trial Info

Start Date :

October 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

162 Patients enrolled

Trial Details

Trial ID

NCT06021990

Start Date

October 1 2023

End Date

December 31 2024

Last Update

October 3 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Pulmonology Department, Lady Reading Hospital, Peshawar

Peshawar, Khyber Pakhtunkhwa, Pakistan, 25000

2

Saidu Teaching Hospital, Swat

Swāt, Khyber Pakhtunkhwa, Pakistan, 19110